Search
- Jun 3, 2023
Biosimilars, toripalimab, and TIGIT with the CEO of Coherus.
Coherus CEO Denny Lanfear talks about trying to lower the cost of medicines through biosimilars and discusses his oncology programs.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A